Ken Fisher Agios Pharmaceuticals, Inc. Call Options Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.2MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$253 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$246 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$218 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$174 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$125 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.46B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...